Stockscreener 앱 받기
38.13
0.94%
-0.36
전일 마감가:
$38.49
열려 있는:
$38.44
하루 거래량:
329.97K
Relative Volume:
0.37
시가총액:
$2.20B
수익:
$772.53M
순이익/손실:
$180.90M
주가수익비율:
12.29
EPS:
3.1024
순현금흐름:
$258.73M
1주 성능:
+0.85%
1개월 성능:
+7.23%
6개월 성능:
+19.68%
1년 성능:
+9.82%
1일 변동 폭
$37.94
$38.52
1주일 범위
$37.47
$39.60
52주 변동 폭
$25.52
$40.93
하모니 바이오 Stock (HRMY) Company Profile
명칭
Harmony Biosciences Holdings Inc
전화
(484) 539-9800
주소
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
HRMY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
38.13 | 2.22B | 772.53M | 180.90M | 258.73M | 3.1024 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.90 | 117.47B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.97 | 82.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.59 | 52.94B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
844.92 | 52.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.88 | 37.84B | 447.02M | -1.18B | -906.14M | -6.1812 |
하모니 바이오 Stock (HRMY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-12-17 | 개시 | H.C. Wainwright | Buy |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-09-10 | 개시 | UBS | Buy |
| 2024-06-21 | 개시 | Citigroup | Buy |
| 2024-01-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-25 | 다운그레이드 | Goldman | Neutral → Sell |
| 2023-09-07 | 개시 | Berenberg | Buy |
| 2023-04-20 | 개시 | BofA Securities | Neutral |
| 2022-10-14 | 업그레이드 | Janney | Neutral → Buy |
| 2022-10-14 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-04 | 개시 | Raymond James | Outperform |
| 2021-09-23 | 개시 | Needham | Buy |
| 2021-03-29 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-14 | 개시 | Goldman | Neutral |
| 2020-09-14 | 개시 | Jefferies | Buy |
| 2020-09-14 | 개시 | Piper Sandler | Overweight |
모두보기
하모니 바이오 주식(HRMY)의 최신 뉴스
26,279 Shares in Harmony Biosciences Holdings, Inc. $HRMY Acquired by Paradiem LLC - MarketBeat
Exchange Traded Concepts LLC Buys 32,923 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings Inc Stock Analysis and ForecastWeekly Market Snapshot & Rapid Profit Portfolio - earlytimes.in
Quarterly Trades: What is the fair value of Harmony Biosciences Holdings Inc stock nowTrade Risk Summary & Daily Oversold Stock Bounce Ideas - moha.gov.vn
Why Harmony Biosciences Holdings Inc. stock is popular among millennials2025 Growth vs Value & Daily Market Momentum Tracking - Улправда
Price-Driven Insight from (HRMY) for Rule-Based Strategy - Stock Traders Daily
Can Harmony Biosciences Holdings Inc. stock maintain operating marginsJuly 2025 Gainers & Reliable Volume Spike Alerts - Улправда
Harmony’s Epilepsy Drug Cuts Seizures in Half in Key Late-Stage Study - MyChesCo
Will Harmony Biosciences Holdings Inc. stock outperform growth indexesMarket Risk Report & Community Verified Trade Alerts - DonanımHaber
Why Harmony Biosciences Holdings Inc. stock attracts high net worth investors2025 Price Targets & Daily Entry Point Alerts - DonanımHaber
Why Harmony Biosciences Holdings Inc. stock appeals to dividend seekersJuly 2025 Outlook & Verified Chart Pattern Trade Signals - DonanımHaber
Will Harmony Biosciences Holdings Inc. stock outperform value stocksBull Run & Safe Entry Momentum Tips - Улправда
Downgrade Watch: Is Harmony Biosciences Holdings Inc. stock positioned well for digital economyWatch List & Stepwise Swing Trade Plans - DonanımHaber
Dow Update: Will Harmony Biosciences Holdings Inc. stock outperform Dow Jones indexWeekly Trend Summary & Long-Term Growth Plans - Улправда
How sustainable is Harmony Biosciences Holdings Inc. stock dividend payoutEarnings Growth Summary & Trade Opportunity Analysis Reports - Улправда
Is Harmony Biosciences Holdings Inc. stock resilient to inflation2025 Winners & Losers & Community Consensus Trade Signals - Улправда
Harmony Biosciences (NASDAQ:HRMY) Trading Down 3.9% After Insider Selling - MarketBeat
Street Watch: Will Harmony Biosciences Holdings Inc. stock outperform international peersJuly 2025 Analyst Calls & Expert Verified Stock Movement Alerts - Улправда
Aug Wrap: How sustainable is Harmony Biosciences Holdings Inc. stock dividend payoutJuly 2025 Breakouts & Technical Entry and Exit Alerts - Улправда
Will Harmony Biosciences Holdings Inc. stock outperform Dow Jones indexPortfolio Performance Summary & Accurate Intraday Trading Signals - Улправда
Harmony Biosciences (NASDAQ:HRMY) CEO Sells $1,040,172.63 in Stock - MarketBeat
Harmony Biosciences Holdings CEO Sells All Directly Owned Common Stock - TradingView — Track All Markets
Harmony Biosciences CEO reports option exercise and share sale | HRMY SEC FilingForm 4 - Stock Titan
Harmony Biosciences partners with Beacon for EEG data in sleep trials - Investing.com Nigeria
Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG - Investing News Network
Harmony Biosciences partners with Beacon for EEG data in sleep trials By Investing.com - Investing.com South Africa
Beacon Biosignals announces partnership with Harmony Biosciences - marketscreener.com
Nomura Holdings Inc. Raises Stock Holdings in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Harmony Biosciences Appoints Ron Philip to Board of Directors - MSN
Growth Value: Will Harmony Biosciences Holdings Inc stock pay special dividendsTrade Ideas & Real-Time Buy Zone Alerts - moha.gov.vn
Federated Hermes Inc. Reduces Stock Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Shows Niche Pharma Momentum Nasdaq Today - Kalkine Media
What analysts say about Harmony Biosciences Holdings Inc stockAutomated Trading Signals & Missed Nvidia? Don’t Miss This One - earlytimes.in
Harmony Biosciences CFO Kapadia Sandip Sells 20,000 Shares - TradingView — Track All Markets
Harmony Advances Pitolisant GR After Bioequivalence Success - Sleep Review
Harmony Biosciences Prepares to Court Investors at Key December Healthcare Conferences - MSN
Harmony Biosciences (HRMY) Shares Promising Phase 3 Trial Results for EPX-100 - GuruFocus
Harmony Biosciences reports positive data for Dravet syndrome drug By Investing.com - Investing.com South Africa
Harmony Biosciences shows seizure reduction in dravet syndrome trial - StreetInsider
Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome - Business Wire
Marshall Wace LLP Increases Stock Holdings in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences reports positive data for Dravet syndrome drug - Investing.com
Harmony’s Next-Gen Narcolepsy Drug Advances With Surprising New Results - MyChesCo
Arrowstreet Capital Limited Partnership Grows Holdings in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Capital Fund Management S.A. Invests $1.14 Million in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
How supply chain issues affect Harmony Biosciences Holdings Inc. stockDividend Hike & Smart Allocation Stock Reports - Newser
How analysts rate Harmony Biosciences Holdings Inc. stock today2025 Trading Recap & Fast Exit and Entry Strategy Plans - Newser
Harmony Biosciences Holdings, I (HRMY) Stock Forecasts - Yahoo Finance
Harmony Biosciences stock maintains Buy rating at H.C. Wainwright after positive trial data By Investing.com - Investing.com South Africa
하모니 바이오 (HRMY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
0.21%
자본화:
|
볼륨(24시간):